A 1-year Multi-center, Prospective, Cohort Study in Patients With Chronic Obstructive Pulmonary Disease Treated With Long-acting Bronchodilator
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Indacaterol (Primary) ; Budesonide/formoterol; Salmeterol/fluticasone propionate; Theophylline; Tiotropium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Novartis Pharmaceuticals
- 06 May 2016 Status changed from recruiting to completed.
- 02 Jan 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Aug 2015 to 1 May 2015.
- 02 Jan 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Aug 2015 to 1 May 2015.